Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lobular Carcinoma In Situ”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT06860217
What this trial is testing

Robotic Nipple Sparing Mastectomy with Immediate Reconstruction

Who this might be right for
Breast CancerDCISBRCA Mutation
European Institute of Oncology 24
Not applicableStudy completedNCT04022772
What this trial is testing

Effect of PACK Health Support Program on Patient Reported Outcomes in Patients With Breast Cancer

Who this might be right for
Breast CarcinomaBreast Ductal Carcinoma In SituInvasive Breast Carcinoma+1 more
M.D. Anderson Cancer Center 287
Not applicableLooking for participantsNCT07339306
What this trial is testing

A Novel Fluorescent Ductal Needle for Localization and Sampling of Micro Lesions in Breast Ducts

Who this might be right for
Mammary TumorNipple DischargeBreast Ductal Carcinoma In Situ
The Fourth Affiliated Hospital of China Medical University 300
Large-scale testing (Phase 3)Study completedNCT00053898
What this trial is testing

Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy

Who this might be right for
Breast Cancer
NSABP Foundation Inc 3,104
Testing effectiveness (Phase 2)Study completedNCT02694809
What this trial is testing

The PROMISE Study: Duavee in Women With DCIS

Who this might be right for
Ductal Breast Carcinoma In SituPostmenopausal
Northwestern University 142
Not applicableStudy completedNCT03775213
What this trial is testing

Acceptability of Active Monitoring (AM) as a Treatment Option for Ductal Carcinoma in Situ (DCIS)

Who this might be right for
Ductal Carcinoma in Situ
Duke University 322
Testing effectiveness (Phase 2)Looking for participantsNCT06075953
What this trial is testing

DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment

Who this might be right for
Ductal Carcinoma in Situ
QuantumLeap Healthcare Collaborative 400
Large-scale testing (Phase 3)Looking for participantsNCT07762885
What this trial is testing

Omission of Adjuvant Radiotherapy in Low- and Intermediate-Risk Ductal Carcinoma In Situ After Breast-Conserving Surgery

Who this might be right for
Ductal Carcinoma In Situ, DCIS
Fudan University 636
Not applicableLooking for participantsNCT05463796
What this trial is testing

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Who this might be right for
Cancer RiskCancer Predisposition SyndromeHereditary Cancer Prediction+28 more
Dana-Farber Cancer Institute 5,000
Very early researchActive Not RecruitingNCT02872025
What this trial is testing

Immunotherapy in High-risk Ductal Carcinoma in Situ (DCIS)

Who this might be right for
Carcinoma, Intraductal, Noninfiltrating
Laura Esserman 42
Not applicableUnknownNCT02389686
What this trial is testing

Intra-operative Radiotherapy For Breast Cancer Women After NSM

Who this might be right for
Breast Neoplasms
Liao Ning 110
Not applicableWithdrawnNCT00083044
What this trial is testing

Ductal Lavage in Assessing Women With Early Breast Cancer or at High Risk of Developing Breast Cancer and Who Are Eligible For Tamoxifen Therapy

Who this might be right for
Breast Cancer
Northwestern University
Not applicableStudy completedNCT05086705
What this trial is testing

EMBr Wave for the Reduction of Hot Flashes in Women With a History of Breast Cancer

Who this might be right for
Breast CarcinomaBreast Ductal Carcinoma In SituBreast Lobular Carcinoma In Situ+1 more
Ohio State University Comprehensive Cancer Center 50
Not applicableWithdrawnNCT00041353
What this trial is testing

Comparison of Biomarkers Based on Fine-Needle Aspiration in Women at Increased or Normal Risk of Breast Cancer

Who this might be right for
Breast Cancer
Fox Chase Cancer Center
Not applicableStudy completedNCT00084669
What this trial is testing

Venlafaxine With or Without Zolpidem in Treating Hot Flashes and Associated Sleep Disorders in Women With Breast Cancer OR at High Risk for Developing Breast Cancer

Who this might be right for
Breast CancerHot FlashesSleep Disorders
Massachusetts General Hospital 119
Not applicableStudy completedNCT01107080
What this trial is testing

Fast Spectral Imaging Device for Tumor Margin Mapping

Who this might be right for
Breast Cancer
Duke University 54
Not applicableStudy completedNCT01208974
What this trial is testing

Nipple-Areola Complex (NAC) Irradiation After Nipple-Sparing Mastectomy and Reconstruction

Who this might be right for
Breast CancerDuctal Carcinoma
University of Miami 21
Not applicableLooking for participantsNCT06903468
What this trial is testing

Novel Cavity Marking Technique in Breast Cancer Patients Undergoing Breast Conservation Surgery With Oncoplastic Reconstruction for the Delivery of Adjuvant Radiotherapy and Accuracy of Recommended Re-excisions

Who this might be right for
Ductal Carcinoma in SituBreast Cancer
University of Florida 50
Early research (Phase 1)Study completedNCT00637481
What this trial is testing

A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer

Who this might be right for
Atypical Ductal Breast HyperplasiaBreast CancerDuctal Breast Carcinoma in Situ+1 more
National Cancer Institute (NCI) 66
Not applicableWithdrawnNCT04349111
What this trial is testing

An Efficacy Study of the Xoft® Axxent® eBx® IORT System® "Lite"

Who this might be right for
Invasive Ductal CarcinomaDuctal Carcinoma In Situ
Xoft, Inc.
Next Page